A recent study evaluating a world‐wide series of over 500 cases of cervical cancer, including rare histotypes and HPV‐negative carcinomas, showed that 98.3% tested positive for FAM19A4/miR124‐2 methylation.25 Here, TAFA4 is linked to cervical carcinoma.